Genetics & Molecular Biology30 March 2026

Catching Sneaky Viruses: How a New Approach to CRISPR Screening Works

Source PublicationProceedings of the National Academy of Sciences

Primary AuthorsWaild, Ciesla, Schafer et al.

Visualisation for: Catching Sneaky Viruses: How a New Approach to CRISPR Screening Works
Visualisation generated via Synaptic Core

Imagine your cell is a massive, highly automated factory with 20,000 different control switches. A virus is a clever intruder trying to hijack the assembly line to print copies of itself.

These results were observed under controlled laboratory conditions, so real-world performance may differ.

To figure out which switches the intruder relies on, scientists normally flip them off one by one and use blunt selection strategies to see what happens. This tactic often misses the subtle ways the intruder manipulates the machinery.

For years, scientists have relied on CRISPR screening to find out exactly which genes viruses need to infect us. They use the famous gene-editing tool to knock out thousands of genes across millions of cells, then expose those cells to a virus.

The problem? Most older methods rely on selection strategies that limit what scientists can actually see. If a gene is involved in a specific, quiet stage of the viral life cycle, the standard screen simply overlooks it.

A Smarter Approach to CRISPR Screening

To fix this blind spot, researchers built a new pipeline called VIRCAA. Instead of relying on those limited selection methods, this pipeline measures virally induced remodelling of cellular antibody affinity. In other words, it tracks how the virus alters the way specific antibodies bind to the cell at different stages of the invasion.

It acts like a smart security camera for our cellular factory. It allows researchers to spot exactly which cellular switches matter, from the moment the virus enters to the second it tries to replicate.

The team tested this by looking at human cytomegalovirus (HCMV), a common pathogen. They focused on a specific viral protein called UL26, which is known for jamming the cell's alarm systems.

Using their new setup, they measured exactly how the cell fights back. They found that a cellular protein named JUNB acts as a fierce defender.

The study measured several specific defence tactics:

  • JUNB drives the expression of antiviral genes to warn the rest of the cell.
  • It tags other proteins with a chemical marker to disrupt the viral machinery.
  • It attempts to physically clump the virus's DNA together to stop it from copying itself.

However, the virus fights dirty. The data shows that the viral UL26 protein directly interacts with JUNB, neutralising its ability to trap the viral DNA.

What This Means for Virus Research

This new method offers a much clearer picture of the microscopic tug-of-war happening inside our cells. By mapping exactly how viruses bypass our cellular security, scientists can better understand the fundamental rules of infection.

While these findings are currently limited to laboratory studies of HCMV, mapping this cellular security breach reveals how viral invaders operate at a molecular level. Furthermore, this upgraded tool may help researchers map out the weak points of many other viruses in the lab.

Cite this Article (Harvard Style)

Waild et al. (2026). 'Cellular antibody affinity-based CRISPR screening identifies JUNB as a broadly acting antiviral factor. '. Proceedings of the National Academy of Sciences. Available at: https://doi.org/10.1073/pnas.2534154123

Source Transparency

This intelligence brief was synthesised by The Synaptic Report's autonomous pipeline. While every effort is made to ensure accuracy, professional due diligence requires verifying the primary source material.

Verify Primary Source
GeneticsHow does the HCMV UL26 protein block antiviral signaling?What is the role of JUNB in antiviral gene expression?CRISPR